KLOW is a precision-formulated multi-peptide research blend combining four synergistic bioactive compounds β GHK-Cu (50mg), KPV (10mg), BPC-157 (10mg), and TB-500 (10mg) β each targeting distinct but complementary molecular pathways in tissue repair, inflammation regulation, extracellular matrix remodeling, and regenerative biology.
GHK-Cu modulates TGF-Ξ², SMAD, and MMP signaling to drive collagen and elastin synthesis and broad regenerative gene expression; KPV inhibits NF-ΞΊB and MAPK cytokine signaling as a selective anti-inflammatory tripeptide; BPC-157 activates VEGF and nitric oxide pathways to enhance angiogenesis and fibroblast-driven matrix deposition; and TB-500 regulates actin polymerization and cell migration via the G-actin-TΞ²4 complex to drive endothelial and tissue regeneration.
The single-vial combination enables researchers to study coordinated multi-pathway regenerative responses β spanning wound healing, musculoskeletal repair, gut integrity, neuroinflammation, and anti-aging biology β within a standardized, reproducible experimental framework.
Specifications:
- Purity: β₯99% (HPLC verified)
- Form: Lyophilized powder
- Storage: β20Β°C
For Research Use Only.






Reviews
There are no reviews yet.